Cardinal Health, Inc. (CAH)
NYSE: CAH · Real-Time Price · USD
205.71
+3.97 (1.97%)
At close: Jun 5, 2026, 4:00 PM EDT
207.43
+1.72 (0.84%)
After-hours: Jun 5, 2026, 7:40 PM EDT

Cardinal Health Stock Forecast

Stock Price Forecast

According to 17 analysts polled by S&P Global, Cardinal Health stock has a consensus rating of "Strong Buy" and an average price target of $245.27. The average 1-year stock price forecast is 19.23% higher than the current stock price, while the lowest is $215 (+4.52%) and the highest is $275 (+33.68%).

Price Target: $245.27 (+19.23%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$215$245.27$245$275
Change+4.52%+19.23%+19.10%+33.68%

Analyst Ratings

The average analyst rating for Cardinal Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy111111121212
Buy222322
Hold344233
Sell100000
Strong Sell000000
Total171717171717

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Maintains
$240
BuyMaintains$240+16.67%May 14, 2026
Morgan Stanley
Morgan Stanley
Buy
Reiterates
$255
BuyReiterates$255+23.96%May 5, 2026
Argus Research
Argus Research
Buy
Maintains
$248
BuyMaintains$248+20.56%May 5, 2026
J.P. Morgan
J.P. Morgan
Hold
Reiterates
$243$215
HoldReiterates$243$215+4.52%May 4, 2026
Robert W. Baird
Robert W. Baird
Buy
Maintains
$257$248
BuyMaintains$257$248+20.56%May 1, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
255.94B
from 222.58B
Increased by 14.99%
Revenue Next Year
277.26B
from 255.94B
Increased by 8.33%
EPS This Year
10.77
from 8.24
Increased by 30.69%
EPS Next Year
11.98
from 10.77
Increased by 11.23%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingJun 30, 2021Jun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026
Revenue
162.47B181.33B204.98B226.83B222.58B255.94B
Revenue Growth
6.24%11.61%13.04%10.66%-1.87%14.99%
Gross Profit
6.78B6.48B6.87B7.41B8.17B9.57B
Gross Margin
4.17%3.58%3.35%3.27%3.67%3.74%
Operating Income
1.79B1.65B1.79B2.15B2.48B3.51B
Net Income
611.00M-938.00M330.00M852.00M1.56B1.95B
EPS
----8.2410.77
EPS Growth
----9.43%30.69%
Forward PE
9.589.7714.7713.4318.6019.10
Dividend / Share
1.941.971.992.012.032.07
Dividend Growth
-1.45%1.00%0.99%1.00%1.86%
Free Cash Flow
155.75M3.92B2.95B3.97B2.07B3.04B
No. Analysts
-----15
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High257.8B
Avg255.9B
Low254.6B

Revenue Growth

Revenue Growth202620272028
High
15.8%
Avg
15.0%
Low
14.4%

EPS Forecast

EPS202620272028
High10.80
Avg10.77
Low10.71

EPS Growth

EPS Growth202620272028
High
31.1%
Avg
30.7%
Low
30.0%